-transparent.png){kind=logo}
Immortalization of chronic leukaemic B cells by Epstein-Barr virus (EBV) was investigated. Immortalization resistant and susceptible cell populations were defined by chronic lymphocytic leukaemia (CLL) and prolymphocytic leukaemia (PLL) cells respectively. These cell types could be distinguished by the effects of a phorbol ester on [3H]-thymidine incorporation by EBV-infected cells. A synergistic effect was observed in the non-immortalizing CLL samples, whereas this response was inhibited in the immortalizing PLL. Under the conditions used in the study, TPA did not cooperate with EBV to immortalize CLL cells.
Related Publications
E V Walls, and
D H Crawford
January 1992,
Methods in molecular biology (Clifton, N.J.),
E V Walls, and
D H Crawford
November 1993,
Leukemia,
E V Walls, and
D H Crawford
April 2008,
Cell proliferation,
E V Walls, and
D H Crawford
January 1998,
The American surgeon,
E V Walls, and
D H Crawford
March 1999,
Frontiers in bioscience : a journal and virtual library,
E V Walls, and
D H Crawford
January 1997,
Annales de medecine interne,
E V Walls, and
D H Crawford
May 1984,
The New England journal of medicine,
E V Walls, and
D H Crawford
January 1982,
The Yale journal of biology and medicine,
E V Walls, and
D H Crawford
January 1987,
Nature,
E V Walls, and
D H Crawford
December 1986,
In vitro cellular & developmental biology : journal of the Tissue Culture Association,
